IDEAYA Biosciences (IDYA) Announces $80M Proposed Public Offering of Common Stock
Get Alerts IDYA Hot Sheet
Join SI Premium – FREE
IDEAYA Biosciences, Inc. (Nasdaq: IDYA) today announced that it intends to offer and sell up to $80.0 million of shares of its common stock in an underwritten public offering. In addition, IDEAYA intends to grant the underwriters a 30-day option to purchase up to $12.0 million of shares of its common stock. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
J.P. Morgan, Jefferies, Citigroup and Guggenheim Securities are acting as joint book-running managers for the offering.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TikTok owner ByteDance said to secure $29.6bn loan for AI push
- AIxCrypto Holdings (AIXC) files for 4.04M share offering by sellng stockholders
- Jefferies Reiterates Buy Rating on CrowdStrike (CRWD)
Create E-mail Alert Related Categories
Corporate News, Equity OfferingsRelated Entities
JPMorgan, Citi, Jefferies & Co, S3, GuggenheimSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share